| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9319978 | European Urology | 2005 | 8 Pages |
Abstract
Our preliminary data suggest that trastuzumab-based therapy may be safe and effective in metastatic transitional cell carcinoma of the urinary tract. Prospective trials are needed to further investigate this therapeutic option.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Michaël Peyromaure, Florian Scotté, Delphine Amsellem-Ouazana, Annick Vieillefond, Stéphane Oudard, Philippe Beuzeboc,